Stay updated on Nivolumab in Advanced SqNSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced SqNSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe Revision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange Detected- Revision label updated from v3.4.1 to v3.4.2 in the page footer.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. The layout and study information appear unchanged.SummaryDifference0.0%

- Check48 days agoChange DetectedAdds a glossary display and updates footer labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. These changes are cosmetic and metadata updates that do not modify core study data, eligibility criteria, or user actions on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the previous v3.3.3; this is an admin/version update and does not modify study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Locations section was updated with multiple site additions and removals across Europe and other regions, reflecting updated centers for the study.SummaryDifference2%

Stay in the know with updates to Nivolumab in Advanced SqNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.